Reshape Lifesciences Inc.
13F holders, Q3 2024 (September 30)9holders
$5.65avg. 13F price*
At the end of Q3 2024, 9 institutions reported holding Reshape Lifesciences Inc. in their 13F filings. The largest holders were Tower Research Capital LLC (TRC) ($4K), BlackRock, Inc. ($3K) and Bank of America Corp. ($23).
- Company
- Reshape Lifesciences Inc.
- CUSIP
- 76090R309
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $4K |
| Exits | 0 | $0 |
Ownership 9 holders
| Tower Research Capital LLC (TRC) | 0.00% | New | 665 | $4K |
| BlackRock, Inc. | 0.00% | — | 588 | $3K |
| Bank of America Corp. | 0.00% | New | 4 | $23 |
| Danske Bank A/S | 0.00% | New | 2 | $11 |
| Group One Trading LLC | 0.00% | New | 2 | $11 |
| JPMorgan Chase & Co. | 0.00% | New | 1 | $6 |
| Morgan Stanley | 0.00% | New | 1 | $6 |
| CIBC Private Wealth Group LLC | 0.00% | New | 1 | $6 |
| UBS Group AG | 0.00% | New | 1 | $6 |
"% of holder's portfolio" is RESHAPE LIFESCIENCES INC's weight in each manager's 13F, not the share of Reshape Lifesciences Inc. the manager owns.